ARTICLE | Clinical News
MVA F6 HIV- Nef: Began Phase I/II study
February 22, 2000 8:00 AM UTC
Bavarian Nordic Research Institute A/S (CSE:BNRI), Glostrup, Denmark Product: MVA F6 HIV- Nef Business: Infectious diseases Therapeutic category: Gene therapy, Immune stimulation Target: Cytotoxic T l...